

[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI

[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
[ Thu, Mar 30th 2023
] - WOPRAI
Reni Benjamin Reiterated (BPMC) at Buy and Held Target at $114 on, Mar 30th, 2023
Reni Benjamin of JMP Securities, Reiterated "Blueprint Medicines Corporation" (BPMC) at Buy and Held Target at $114 on, Mar 30th, 2023.
Reni has made no other calls on BPMC in the last 4 months.
There are 8 other peers that have a rating on BPMC. Out of the 8 peers that are also analyzing BPMC, 5 agree with Reni's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Benjamin Chaiken of "JMP Securities" Reiterated at Hold and Held Target at $114 on, Tuesday, February 28th, 2023
- Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $38 on, Friday, February 24th, 2023
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $50 on, Friday, January 27th, 2023
- Peter Lawson of "Barclays" Maintained at Hold with Decreased Target to $44 on, Monday, January 23rd, 2023
- Derek Archila of "Wells Fargo" Upgraded from Sell to Hold and Held Target at $41 on, Tuesday, January 3rd, 2023
These are the ratings of the 3 analyists that currently disagree with Reni
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $70 on, Tuesday, February 28th, 2023
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $57 on, Tuesday, February 28th, 2023
- Dane Leone of "Raymond James" Maintained at Strong Buy with Decreased Target to $85 on, Friday, February 17th, 2023
Contributing Sources